Companies / Mexico
Genomma Acquires Antacid Brand
August 2008 | Industry NewsRecently listed Mexican drugmaker Genomma Lab Internacional has acquired the brand Unigastrozol along with the related rights and registrations from Unipharm de Mexico . The drug is sold over the counter (OTC) and is used in the treatment of gastritis, heartburn, reflux and esophagitis. The category of this drug is reported to have reached sales of over US$50mn in 2007.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
